Exchange listing deficiency and compliance notices under 8-K Item 3.01.
Cyngn Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
“February 6, 2025, Cyngn Inc., a Delaware corporation (the “Company”) received a letter (the “Minimum Bid Price Deficiency Letter”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (”
Global Star Acquisition Inc. received a nasdaq delisting notice notice regarding shareholders (rules 5450(a)(2)).
“024, we received a notice from the Staff notifying us that the Company is not in compliance with Listing Rule 5450(a)(2) (the “Minimum Public Holders Rule”), which requires the Company to have at least 400 total holders”
Global Star Acquisition Inc. received a nasdaq deficiency notice notice regarding other (rules 5450(b)(2)(B)).
“November 25, 2024, Global Star Acquisition Inc. (the “Company”) received a letter from the listing qualifications department staff (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company was not i”
Oklo Inc. received a nyse deficiency notice notice regarding audit committee.
“February 5, 2025, the Company received an official notice of non-compliance from the NYSE (the “NYSE Notice”). The NYSE Notice does not have any immediate effect on the listing of the Company’s common stock, which remain”
STRYVE FOODS, INC. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).
“February 4, 2025, the Nasdaq Stock Market LLC (“Nasdaq”) notified Stryve Foods, Inc. (the “Company”) that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the Company’s Class A common stock and warrants a”
Beyond Air, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
“February 5, 2025, Nasdaq notified the Company that its staff (the “Staff”) determined that the Company is eligible for an additional 180 calendar day period, or until August 4, 2025, to regain compliance. The Staff’s det”
ALPHATIME ACQUISITION CORP received a nasdaq extension granted notice regarding shareholders (rules 5450(a)(2)).
“January 29, 2025, Nasdaq issued a notice granting the Company an extension of time to regain compliance with Nasdaq Minimum Total Holders Rule for 180 calendar days, or until May 28, 2025. The terms of the extension are”
Solidion Technology Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5450(a)(1)).
“January 29, 2025, the Company received a Staff determination letter that stated the Company had not regained compliance with the Bid Price Rule, and, as a result, the Company’s common stock is now subject to delisting fr”
Omega Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).
“January 29, 2025, the Company received a written notice (the “Notice”) from The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the bid price for the Company’s co”
NextCure, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).
“January 31, 2025, NextCure, Inc. (the “Company”, “we”, “us”, or “our”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying us that the cl”
Flux Power Holdings, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
“January 31, 2025, Flux Power Holdings, Inc. (the “Company”) received a notice (the “Notice”) from The NASDAQ Stock Market LLC (“Nasdaq”) notifying the Company that based on its stockholders’ equity of $194,000 as reporte”
USBC, Inc. received a nyse_american delisting notice notice regarding minimum bid price (rules 1003(f)(v)).
“January 29, 2025, NYSE American LLC (“ NYSE American ” or the “ Exchange ”) publicly announced and provided a notice to Know Labs, Inc. (the “ Company ”) that the NYSE Regulation has suspended trading of, and determined”
VOXX International Corp received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).
“January 28, 2025, VOXX International Corporation (the "Company") received a letter (the "Letter") from the Nasdaq Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq") notifying the Company that it is n”
Newton Golf Company, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
“Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) due to the Company’s common stock not maintaining a closing bid price of at least $1.00 per share f”
Stran & Company, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
“January 27, 2025, Stran & Company, Inc. (the “Company”) received a written notification (the “Notification Letter”), from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) not”
Alternus Clean Energy, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iv)).
“January 30, 2025, Alternus Clean Energy, Inc., a Delaware corporation (the “Company”) received a letter (the “Minimum Bid Price Deficiency Letter”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq S”
WinVest Acquisition Corp. received a nasdaq deficiency notice notice regarding other (rules 5620(a)).
“January 27, 2025, WinVest Acquisition Corp. (“WinVest” or the “Company”) received a written notice from the staff of the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company t”
Indaptus Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
“January 31, 2025, Indaptus Therapeutics, Inc. (the “Company”) was notified (the “Notification Letter”) by the Nasdaq Listing Qualifications (“Nasdaq”) that it is not in compliance with the minimum bid price requirements”
Passage BIO, Inc. received a nasdaq extension granted notice regarding minimum bid price.
“January 29, 2025, the Nasdaq Listing Qualifications department approved the Company’s request to transfer the listing of the Company’s shares of common stock from The Nasdaq Global Select Market to The Nasdaq Capital Mar”
Cellectar Biosciences, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
“January 30, 2025, Cellectar Biosciences, Inc. (the “Company”) received notice from Nasdaq which indicated that under Nasdaq Listing Rule 5550(a)(2), the Company is required to maintain a minimum bid price for its common”
Viracta Therapeutics, Inc. received a nasdaq delisting notice notice regarding other (rules 5450(a)(1), 5550(b)(1)).
“January 31, 2025, the Company received written notification (the “Delisting Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company’s common stock will be delisted from Nasdaq and trading in the Company’s s”
Accelerate Diagnostics, Inc received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).
“January 28, 2025, Accelerate Diagnostics, Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company t”
Verrica Pharmaceuticals Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).
“January 24, 2025, Verrica Pharmaceuticals, Inc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the listing of its common”
DevvStream Corp. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).
“January 22, 2025, DevvStream Corp. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) stating that the Company is not in compliance with Nas”
Royalty Management Holding Corp received a nasdaq deficiency notice notice regarding other (rules 5620(a)).
“January 24, 2025, Royalty Management Holding Corporation (or the “Company”) received a letter from Nasdaq Regulation (“Nasdaq”) indicating that the Company has not yet held an annual meeting of shareholders within twelve”
GameSquare Holdings, Inc. received a nasdaq deficiency notice notice regarding shareholders (rules 5620(a), 5810(c)(2)(G)).
“January 23, 2025, GameSquare Holdings, Inc. (the “Company”) received a notification letter from the Nasdaq Listing Qualifications department (“Nasdaq”) regarding the timing of its annual meeting of shareholders. Nasdaq n”
Big Digital Energy, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).
“January 24, 2025, Mawson Infrastructure Group Inc. (the “Company”) received written notice (the “MVLS Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying”
Protagenic Therapeutics, Inc.new received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
“January 22, 2025, Nasdaq provided a notice to the Company that the Company had not regained compliance with Rule 5550(a)(2) and is not eligible for a second 180 calendar day compliance period as the Company does not comp”
QT IMAGING HOLDINGS, INC. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5450(a)(1)).
“June 17, 2024, the Staff notified the Company that the minimum bid price of the Company’s common stock had been below $1.00 per share for 30 consecutive business days, and, as a result, did not comply with Listing Rule 5”
QT IMAGING HOLDINGS, INC. received a nasdaq delisting notice notice regarding market value (rules 5450(b)(2)(A)).
“November 6, 2024 that it had determined to commence proceedings to delist the common stock from Nasdaq due to its determination that the Company’s common stock is no longer suitable for listing because the Company’s mark”
Assertio Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
“January 22, 2025, Assertio Holdings, Inc. (the “Company”) notified the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) that it was not in compliance with the minimum $1.00 per share requirement fo”
Allied Gaming & Entertainment Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
“January 22, 2025, Allied Gaming & Entertainment Inc. (the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that”
New Horizon Aircraft Ltd. received a nasdaq compliance regained notice regarding stockholders equity (rules 5550(b)(1)).
“January 24, 2025, the Company received a letter from the Nasdaq Office of General Counsel confirming the decision of the Panel that the Company had regained compliance with the Continued Listing Standards by demonstratin”
Rocky Mountain Chocolate Factory, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5450(b)(1)(A)).
“January 21, 2025, Rocky Mountain Chocolate Factory, Inc. (the “Company”) received a deficiency letter (the “Letter”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) noti”
RELMADA THERAPEUTICS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5810(c)(3)(A)).
“January 21, 2025, Relmada Therapeutics, Inc. (the “Company”) received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the 30 consecu”
Damon Inc. received a nasdaq deficiency notice notice regarding minimum bid price.
“January 22, 2025, Damon Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the”
Technology & Telecommunication Acquisition Corp received a nasdaq delisting notice notice regarding other (rules IM-5101-2).
“January 16, 2025, Technology & Telecommunication Acquisition Corporation (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) stating that, pursuant to Nasdaq”
Zoomcar Holdings, Inc. received a nasdaq delisting notice notice regarding market value (rules 5450(b)(2)(C), 5810(c)(3)(D)).
“January 23, 2025, the Company received a further notice from the Staff, notifying the Company that its failure to regain compliance with the MVPHS Rule serves as an additional basis for delisting the Company’s securities”
Foghorn Therapeutics Inc. received a nasdaq deficiency notice notice regarding audit committee.
“January 23, 2025, Foghorn Therapeutics Inc. (the “Company”) received a notice (the “Notice”) from the Nasdaq Stock Market LLC (the “Nasdaq”) notifying the Company that it no longer complies with Nasdaq’s audit committee”
Lyell Immunopharma, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).
“January 23, 2025, Lyell Immunopharma, Inc. (the “Company”) received notice (the “Notice”) from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 33 consec”
Onconetix, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
“January 23, 2025, Onconetix, Inc. (the “Company”) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s commo”
Canoo Inc. received a nasdaq delisting notice notice regarding other.
“January 22, 2025, the Company received a letter from the staff of the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that the Staff has determined that th”
PAVmed Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
“January 23, 2025, PAVmed Inc. (the “ Company ”) received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) stating that, for the prior 30 consecutive business days (through J”
Cycurion, Inc. received a nasdaq delisting notice notice regarding other (rules IM-5101-2).
“January 16, 2025, Western Acquisition Ventures Corp. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) stating that, pursuant to Nasdaq Listing Rule IM-510”
Lazydays Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
“January 23, 2025, Lazydays Holdings, Inc. (the “ Company ”) received written notice (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that for t”
374Water Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
“January 15, 2025, 374Water Inc. (the “Company”) received a deficiency letter from the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the l”
Aptose Biosciences Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
“January 14, 2025, Aptose Biosciences Inc. (the “Company”) received an additional staff determination letter (the “Letter”) from the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“”
REPUBLIC AIRWAYS HOLDINGS INC. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).
“January 15, 2025, Mesa Air Group, Inc. (the “Company”) received a notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of th”
FutureTech II Acquisition Corp. received a nasdaq extension granted notice regarding late filing (rules 5250(c)(1)).
“January 15, 2024, the Company received a decision letter from the Hearing Panel of Nasdaq (the “ Panel ”) stating that it grants the Company’s request for continued listing on Nasdaq, provided that the Company files 2024”
Wag! Group Co. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C)).
“January 14, 2025, Wag! Group Co. (the “Company”) received a written notice from the staff (the “Staff”) of the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that for 30 con”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.